The current applications of 3D bioprinting products cater to various requirements within the pharmaceutical industry for clinical testing of therapeutic drugs. The ‘3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035’report provides a comprehensive study on the current market landscape of the 3D bioprinting industry, featuring an elaborate discussion on the future potential of this evolving market. Moreover, we’ve also done a recent report on the 4D bioprinting market. Some of the most interesting insights from our study are presented below.
Exemplified by a Strong IP Portfolio, the Industry has Witnessed Significant Innovation Over 250% increase in the number of filed patents in last 10 years further validates the increasing interest from various stakeholders.
Both Industry and Non-Industry Players Are Leading the Research Efforts Currently, there are more than 70 bioprinters being developed by industry and academic players for 3D bioprinting of biological products
North America has Emerged as A Major Hub of Product Manufacturers Several companies are exploring the utility of 3D bioprinters across wide application areas; majority of these efforts are centered in North America.
Bioprinters Vary in terms of Range of Applications and Technological Competence In fact, to emerge as leaders in this highly lucrative domain, companies are developing multiple products for various applications.
The Rising Number of Collaborations will Act as a Key Enabler A large number of well-funded companies have recently entered into strategic collaborations to explore novel opportunities
The Approach Has Also Gained Popularity on Social Media In addition, specific fields, such as stem cell research and tissue engineering, have continued to drive attention on social media platforms.
A Steady Future Growth, Likely to Be Fueled by 3D Bioprinted Organs in the Long Term Driven by high unmet demand for organ transplants and lack of appropriate clinical models for drug testing, we expect the future market to be worth multi-billion dollars.
Overall, a Well-Distributed Opportunity Across Technologies, Applications & Geographies A closer look at the 3D bioprinting market landscape reveals a well distributed opportunity in terms of application areas, bioprinting technologies and geographies
Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT & technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.